Literature DB >> 26584624

Epidemic myalgia and myositis associated with human parechovirus type 3 infections occur not only in adults but also in children: findings in Yamagata, Japan, 2014.

K Mizuta1, T Yamakawa2, K Kurokawa2, S Chikaoka3, Y Shimizu4, T Itagaki5, F Katsushima6, Y Katsushima6, S Ito7, Y Aoki1, Y Matoba1, S Tanaka1, K Yahagi1.   

Abstract

We previously reported an association between human parechovirus type 3 (HPeV3) and epidemic myalgia with myositis in adults during summers in which an HPeV3 outbreak occurred in children. However, this disease association has not yet been reported elsewhere. We have since continued our surveillance to accumulate data on this disease association and to confirm whether myalgia occurs in children as well as adults. Between June and August 2014, we collected 380 specimens from children with infectious diseases. We also collected clinical specimens from two adult and three paediatric patients suspected of myalgia. We then performed virus isolation and reverse-transcription-PCR using the collected specimens. We detected HPeV3 in 26 children with infectious diseases, which we regarded as indicating an outbreak. We also confirmed HPeV3 infection in all patients suspected of myalgia. In particular the symptoms in two boys, complaining of myalgia and fever, closely matched the criteria for adult myalgia. Based on our findings from 2008, 2011 and 2014, we again urge that clinical consideration be given to the relationship between myalgia and HPeV3 infections during HPeV3 outbreaks in children. Furthermore, our observations from 2014 suggest that epidemic myalgia and myositis occur not only in adults but also in children.

Entities:  

Keywords:  Adult; HPeV3; child; myalgia; myositis

Mesh:

Year:  2015        PMID: 26584624     DOI: 10.1017/S0950268815002873

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  6 in total

Review 1.  Human Parechovirus: an Increasingly Recognized Cause of Sepsis-Like Illness in Young Infants.

Authors:  Laudi Olijve; Lance Jennings; Tony Walls
Journal:  Clin Microbiol Rev       Date:  2017-11-15       Impact factor: 26.132

2.  Strain-dependent neutralization reveals antigenic variation of human parechovirus 3.

Authors:  Eveliina Karelehto; Sabine van der Sanden; James A Geraets; Aušra Domanska; Lonneke van der Linden; Dionne Hoogendoorn; Gerrit Koen; Hetty van Eijk; Shabih Shakeel; Tim Beaumont; Menno de Jong; Dasja Pajkrt; Sarah J Butcher; Katja C Wolthers
Journal:  Sci Rep       Date:  2017-09-21       Impact factor: 4.379

3.  Evolutionary and network analysis of virus sequences from infants infected with an Australian recombinant strain of human parechovirus type 3.

Authors:  Soren Alexandersen; Tiffanie M Nelson; Jason Hodge; Julian Druce
Journal:  Sci Rep       Date:  2017-06-20       Impact factor: 4.379

4.  An outbreak of severe infections among Australian infants caused by a novel recombinant strain of human parechovirus type 3.

Authors:  Tiffanie M Nelson; Peter Vuillermin; Jason Hodge; Julian Druce; David T Williams; Rekha Jasrotia; Soren Alexandersen
Journal:  Sci Rep       Date:  2017-03-14       Impact factor: 4.379

5.  Seropositivity and epidemiology of human parechovirus types 1, 3, and 6 in Japan.

Authors:  K Watanabe; C Hirokawa; T Tazawa
Journal:  Epidemiol Infect       Date:  2016-08-30       Impact factor: 4.434

Review 6.  Severe epidemic myalgia with an elevated level of serum interleukin-6 caused by human parechovirus type 3: a case report and brief review of the literature.

Authors:  Kiwamu Nakamura; Kyoichi Saito; Yasuka Hara; Tetsuji Aoyagi; Kadzuhiro Kitakawa; Yoshinobu Abe; Hiromu Takemura; Fumihito Ikeda; Mitsuo Kaku; Keiji Kanemitsu
Journal:  BMC Infect Dis       Date:  2018-08-07       Impact factor: 3.090

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.